Adial Pharmaceuticals, Inc. WT EXP 073123 – NASDAQ:ADILW
Adial Pharmaceuticals, Inc. WT EXP 073123 stock price monthly change
Adial Pharmaceuticals, Inc. WT EXP 073123 stock price quarterly change
Adial Pharmaceuticals, Inc. WT EXP 073123 stock price yearly change
Adial Pharmaceuticals, Inc. WT EXP 073123 key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -0.06 |
EV/Sales | N/A |
EV/EBITDA | 0.12 |
Price/Sales | N/A |
Price/Book | 0.40 |
PEG ratio | N/A |
EPS | -5.90 |
Revenue | N/A |
EBITDA | -6.46M |
Income | -8.69M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAdial Pharmaceuticals, Inc. WT EXP 073123 stock price history
Adial Pharmaceuticals, Inc. WT EXP 073123 stock forecast
Adial Pharmaceuticals, Inc. WT EXP 073123 financial statements
| Jun 2023 | 0 | 1.08M | |
|---|---|---|---|
| Sep 2023 | 0 | -1.38M | |
| Dec 2023 | 32.24K | -1.92M | -5955.26% |
| Mar 2024 | 0 | -6.47M |
| Jun 2023 | 3778943 | 461.75K | 12.22% |
|---|---|---|---|
| Sep 2023 | 2867437 | 528.17K | 18.42% |
| Dec 2023 | 4737042 | 653.51K | 13.8% |
| Mar 2024 | 6684381 | 562.73K | 8.42% |
| Jun 2023 | -1.89M | 800K | 58 |
|---|---|---|---|
| Sep 2023 | -1.39M | 350K | 138.66K |
| Dec 2023 | -1.22M | 350K | 3.38M |
| Mar 2024 | -1.62M | 0 | 3.82M |
Adial Pharmaceuticals, Inc. WT EXP 073123 other data
| Period | Buy | Sel |
|---|---|---|
| Apr 2021 | 0 | 150000 |
| Oct 2021 | 0 | 200000 |
| Nov 2021 | 30600 | 0 |
| Dec 2021 | 25000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | NEWMAN JAMES W. JR. director | Common Stock | 10,000 | $2.71 | $27,100 | ||
Purchase | NEWMAN JAMES W. JR. director | Common Stock | 5,000 | $2.72 | $13,600 | ||
Purchase | NEWMAN JAMES W. JR. director | Common Stock | 10,000 | $2.66 | $26,600 | ||
Purchase | STILLEY WILLIAM B. III director, 10 perc.. | Common Stock | 10,600 | $2.75 | $29,182 | ||
Purchase | STILLEY WILLIAM B. III director, 10 perc.. | Common Stock | 10,000 | $2.59 | $25,890 | ||
Purchase | NEWMAN JAMES W. JR. director | Common Stock | 10,000 | $2.85 | $28,500 | ||
Sale | JOHNSON BANKOLE A. officer: Chief Medical Officer | Common Stock | 200,000 | N/A | N/A | ||
Sale | JOHNSON BANKOLE A. officer: Chief Medical Officer | Common Stock | 150,000 | $2.5 | $375,000 | ||
Sale | JOHNSON BANKOLE A. officer: Chief Medical Officer | Common Stock | 350,000 | $1.21 | $423,500 | ||
Purchase | NEWMAN JAMES W. JR. director | Common Stock | 19,644 | $1.37 | $26,912 |
-
When is Adial Pharmaceuticals, Inc. WT EXP 073123's next earnings date?
Unfortunately, Adial Pharmaceuticals, Inc. WT EXP 073123's (ADILW) next earnings date is currently unknown.
-
Does Adial Pharmaceuticals, Inc. WT EXP 073123 pay dividends?
No, Adial Pharmaceuticals, Inc. WT EXP 073123 does not pay dividends.
-
What is Adial Pharmaceuticals, Inc. WT EXP 073123's stock symbol?
Adial Pharmaceuticals, Inc. WT EXP 073123 is traded on the NASDAQ under the ticker symbol "ADILW".
-
How do i buy shares of Adial Pharmaceuticals, Inc. WT EXP 073123?
Shares of Adial Pharmaceuticals, Inc. WT EXP 073123 can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Adial Pharmaceuticals, Inc. WT EXP 073123 went public?
Adial Pharmaceuticals, Inc. WT EXP 073123 is publicly traded company for more then 7 years since IPO on 27 Jul 2018.